[Funding alert] London-based Vitrue Health Secures €3.7 Million in Funding
Feb 29, 2024 | By Team SR
London-based Vitrue Health secures €3.7 million in funding taking their total raised to €6.5 million, to improve the way employers assess, prevent, and treat MSK conditions at work. The investment was led by MMC Ventures and Hambro Perks, with participation from Chris Bruce, Crista Galli Ventures, and Simplyhealth Ventures.
Read also - Ankara-based Rototip Raises €1Million in Funding
The money will be utilized to expand the team's reach throughout the US and into new European markets. Research on clinical use cases and other evaluation modalities will also be funded by the money.
RECOMMENDED FOR YOU
[Funding alert] Threedy Secures $10.4Million in Latest Series A Round Funding
Team SR
Mar 5, 2024
Shane Lowe, Co-Founder and CEO at Vitrue Health, said: “Musculoskeletal health conditions have been a societal problem across the world for decades, and our data shows that rates of pain have massively increased since the rise of hybrid working. With this new funding, we’ll be able to continue our growth to reduce the financial and health costs for employers and their teams.”
Rheumatoid arthritis, chronic back disorders, and short-term ailments like muscular strain are among the estimated 1.7 billion persons affected by MSK diseases worldwide, which frequently present as back and neck pain. MSK diseases cost British companies 30 million workdays annually, or 24% of all working days missed due to illness at work.
developed as a result of co-founders Shane Lowe's PhD in sophisticated motion capture technology for injury prediction and Alexandra Haslehurst's master's degree in biomechanics from Cambridge University.
Read also - Paris-based Bolero Secures €2 Million in Seed Funding
Vitrue Health delivers a personalized program to enhance the equipment use, behavior, risk prevention, injury management, and even psychology of home, site, and office-based workers. It does this by using computer vision and artificial intelligence to analyze the posture and ergonomics of these workers.
Simon Menashy, Partner at MMC Ventures, added: “We’ve been tracking Vitrue Health and the evolution of its computer vision technology for several years. The team is highly technical with a strong clinical skill set, and we believe they’ve found a strong use case with evidenced product-market fit that can eliminate musculoskeletal pain for millions of people.”
Nick Sharp, Partner at Hambro Perks, commented: “Vitrue has made great progress in its vision to fix a global pain point with their unique tech solution. We’ve been very impressed with the product and commercial development, and the evidence showing prevention in MSK issues and a reduction in pain for those living with conditions.”
About Vitrue Health
Vitrue Health minimize needless musculoskeletal problems (such as back, neck, and shoulder discomfort) in the workplace by utilizing the most recent advancements in computer vision, biomechanics, and clinical decision support technology.